TGA Approval

APO-RISEDRONATE risedronate sodium (as hemipentahydrate) 35 mg tablet blister pack (160642)

ARTG ID

160642

ARTG Name

APO-RISEDRONATE risedronate sodium (as hemipentahydrate) 35 mg tablet blister pack

Sponsor

Arrotex Pharmaceuticals Pty Ltd

ARTG Date

November 11, 2010

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Arrotex Pharmaceuticals Pty Ltd.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01121-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01120-1

Ingredient Name

risedronate sodium hemipentahydrate

Empowering clinical research with data-driven insights and AI-powered tools.

APO-RISEDRONATE risedronate sodium (as hemipentahydrate) 35 mg tablet blister pack (160642) - TGA 批准文号 | MedPath